Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Cyclizine lactate |
Is a |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Phenyltoloxamine citrate |
Is a |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Buclizine hydrochloride |
Is a |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Bromazine hydrochloride |
Is a |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Mepyramine maleate |
Is a |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Doxylamine (substance) |
Is a |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Alimemazine tartrate |
Is a |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Chlorcyclizine |
Is a |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Levocabastine (substance) |
Is a |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Azatadine (substance) |
Is a |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Triprolidine (substance) |
Is a |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Diphenhydramine (substance) |
Is a |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Cyproheptadine (substance) |
Is a |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Clemastine (substance) |
Is a |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Brompheniramine (substance) |
Is a |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Hydroxyzine (substance) |
Is a |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Promethazine (substance) |
Is a |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Meclozine (substance) |
Is a |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Carbinoxamine (substance) |
Is a |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Chlorphenamine |
Is a |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Pheniramine (substance) |
Is a |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Antazoline (substance) |
Is a |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Pyrilamine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Product containing dimetindene (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Sedating antihistamine adverse reaction |
Causative agent (attribute) |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Mebhydrolin adverse reaction |
Causative agent (attribute) |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Mequitazine adverse reaction |
Causative agent (attribute) |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Oxatomide adverse reaction |
Causative agent (attribute) |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Meclozine hydrochloride adverse reaction |
Causative agent (attribute) |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Dimethindene adverse reaction |
Causative agent (attribute) |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Diphenylpyraline adverse reaction |
Causative agent (attribute) |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Mepyramine adverse reaction |
Causative agent (attribute) |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Trimeprazine adverse reaction (disorder) |
Causative agent (attribute) |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Sedating antihistamine allergy |
Causative agent (attribute) |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Allergy to mebhydrolin (finding) |
Causative agent (attribute) |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Allergy to mequitazine (finding) |
Causative agent (attribute) |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Allergy to oxatomide |
Causative agent (attribute) |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Allergy to dimetindene |
Causative agent (attribute) |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Allergy to diphenylpyraline (finding) |
Causative agent (attribute) |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Allergy to mepyramine |
Causative agent (attribute) |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Allergy to alimemazine |
Causative agent (attribute) |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Dimethindene maleate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Diphenylpyraline hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Product containing mebhydrolin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Mepyramine maleate [antihistamine] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Product containing mequitazine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Product containing oxatomide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Trimeprazine tartrate [antihistamine] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Alimemazine tartrate 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Trimeprazine tartrate 7.5mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Trimeprazine tartrate 30mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Mepyramine maleate [nausea] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Product containing precisely mepyramine maleate 20 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Trimeprazine tartrate [anesthesia] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Sedating antihistamine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Product containing mepyramine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Bromodiphenhydramine+codeine 12.5mg/5mL/10 mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Acetaminophen + phenyltoloxamine citrate 500mg/30mg caplets |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Paracetamol 500 mg and phenyltoloxamine citrate 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Paracetamol 500 mg and phenyltoloxamine citrate 60 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Phenindamine (substance) |
Is a |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Buclizine (substance) |
Is a |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Chloropyrilene |
Is a |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Dimenhydrinate (substance) |
Is a |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Cyclizine (substance) |
Is a |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Pizotifen (substance) |
Is a |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Cinnarizine (substance) |
Is a |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Product containing phenyltoloxamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Product containing bromazine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Product containing alimemazine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Product containing diphenylpyraline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Mepyramine |
Is a |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Product containing bromazine and codeine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
pyrilamine maleate+benzocaine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Product containing magnesium salicylate and phenyltoloxamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Product containing dexbrompheniramine and mepyramine and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Mequitazine (substance) |
Is a |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Ethanolamine adverse reaction |
Causative agent (attribute) |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Allergy to ethanolamine (finding) |
Causative agent (attribute) |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Product containing mepyramine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Ethanolamine agent |
Is a |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Ethanolamine derivative antihistamine |
Is a |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Propylamine derivative antihistamine |
Is a |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Piperazine derivative antihistamine |
Is a |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Alimemazine |
Is a |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Mebhydrolin (substance) |
Is a |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Oxatomide (substance) |
Is a |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Ethanolamine |
Is a |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Allergy to ethanolamine (finding) |
Causative agent (attribute) |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Ethanolamine adverse reaction |
Causative agent (attribute) |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|
Sedating antihistamine allergy |
Causative agent (attribute) |
False |
Sedating antihistamine |
Inferred relationship |
Some |
1 |
Ketotifen (substance) |
Is a |
False |
Sedating antihistamine |
Inferred relationship |
Some |
|